These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22184186)

  • 21. Dopamine-glutamate interactions: a neural convergence mechanism of common schizophrenia risk variants.
    Tost H; Meyer-Lindenberg A
    Biol Psychiatry; 2011 May; 69(10):912-3. PubMed ID: 21515141
    [No Abstract]   [Full Text] [Related]  

  • 22. Postmortem neurochemistry in schizophrenia.
    Bracha HS; Kleinman JE
    Psychiatr Clin North Am; 1986 Mar; 9(1):133-41. PubMed ID: 2421270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The GABA-glutamate connection in schizophrenia: which is the proximate cause?
    Coyle JT
    Biochem Pharmacol; 2004 Oct; 68(8):1507-14. PubMed ID: 15451393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-methyl-D-aspartate antagonists as drug models of schizophrenia: a surprising link to tobacco smoking.
    Domino EF; Mirzoyan D; Tsukada H
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Aug; 28(5):801-11. PubMed ID: 15363604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How do glial-neuronal interactions fit into current neurotransmitter hypotheses of schizophrenia?
    Kondziella D; Brenner E; Eyjolfsson EM; Sonnewald U
    Neurochem Int; 2007 Jan; 50(2):291-301. PubMed ID: 17084946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Schizophrenia: diverse approaches to a complex disease.
    Sawa A; Snyder SH
    Science; 2002 Apr; 296(5568):692-5. PubMed ID: 11976442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular mechanisms underlying glutamatergic dysfunction in schizophrenia: therapeutic implications.
    Gaspar PA; Bustamante ML; Silva H; Aboitiz F
    J Neurochem; 2009 Nov; 111(4):891-900. PubMed ID: 19686383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Towards a clinical methodology for neuropsychopharmacological research.
    Ban TA
    Neuropsychopharmacol Hung; 2007 Jun; 9(2):81-90. PubMed ID: 17970531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postmortem studies in psychiatry.
    Bracha HS; Kleinman JE
    Psychiatr Clin North Am; 1984 Sep; 7(3):473-85. PubMed ID: 6384958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The basal ganglia: anatomy, physiology, and pharmacology.
    Tisch S; Silberstein P; Limousin-Dowsey P; Jahanshahi M
    Psychiatr Clin North Am; 2004 Dec; 27(4):757-99. PubMed ID: 15550292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Biochemistry of schizophrenia and mechanism of action of neuroleptics].
    Loo H; Cuche H; Sechter D
    Sem Hop; 1982 Dec; 58(44):2565-72. PubMed ID: 6130604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Biochemical and genetic aspects of pathogenesis of schizophrenia].
    Kambarova DK; Golubev AG
    Zh Evol Biokhim Fiziol; 2011; 47(5):348-57. PubMed ID: 22145315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How schizophrenia develops: new evidence and new ideas.
    Harv Ment Health Lett; 2001 Feb; 17(8):1-4. PubMed ID: 11175456
    [No Abstract]   [Full Text] [Related]  

  • 34. Schizophrenia.
    Leweke FM
    Curr Top Behav Neurosci; 2009; 1():387-96. PubMed ID: 21104393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropathology of schizophrenia--a review.
    Chaturvedi S; Thakur R
    Indian J Pathol Microbiol; 2003 Apr; 46(2):165-9. PubMed ID: 15022900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Development of the schizophrenia concept and diagnostic tools for its assessment].
    Frydecka D; Kiejna A
    Psychiatr Pol; 2008; 42(4):477-89. PubMed ID: 19189593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Do the glutamate excitotoxicity theory and potential free radicals implication in schizophrenia aetiopathogenesis provide a new enlightenment to links between: genome, environment and biology in the determinism of that disorder?].
    Nguimfack Mbodie PC
    Encephale; 2002; 28(2):147-53. PubMed ID: 11972141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antipsychotics in the early stage of development.
    Biedermann F; Fleischhacker WW
    Curr Opin Psychiatry; 2009 May; 22(3):326-30. PubMed ID: 19346948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations in dopamine and glutamate neurotransmission in tetrahydrobiopterin deficient spr-/- mice: relevance to schizophrenia.
    Choi YK; Tarazi FI
    BMB Rep; 2010 Sep; 43(9):593-8. PubMed ID: 20846490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mayo Seminars in Psychiatry: dopamine and schizophrenia--a review.
    Fredrickson P; Richelson E
    J Clin Psychiatry; 1979 Sep; 40(9):399-405. PubMed ID: 39063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.